Unknown

Dataset Information

0

Apolipoprotein A-I Supports MSCs Survival under Stress Conditions.


ABSTRACT: Clinical trials have shown the safety of mesenchymal stem/stromal cells (MSCs) transplantation, but the effectiveness of these treatments is limited. Since, transplanted MSCs will undergo metabolic disturbances in the bloodstream, we investigated the influence of blood plasmas of type 2 diabetes (T2D) patients on MSCs viability and examined whether apolipoprotein A-I (apoA-I) could protect cells from stressful conditions of serum deprivation (SD), hypoxia, and elevated concentrations of reactive oxygen species (ROS). ApoA-I exhibits anti-inflammatory, immune activities, improves glycemic control, and is suitable for T2D patients but its influence on MSCs remains unknown. For the first time we have shown that apoA-I decreases intracellular ROS and supports proliferative rate of MSCs, thereby increasing cell count in oxidation conditions. ApoA-I did not influence cell cycle when MSCs were predominantly in the G0/G1 phases under conditions of SD/hypoxia, activated proliferation rapidly, and reduced apoptosis during MSCs transition to the oxygenation or oxidation conditions. Finally, it was found that the blood plasma of T2D individuals had a cytotoxic effect on MS?s in 39% of cases and had a wide variability of antioxidant properties. ApoA-I protects cells under all adverse conditions and can increase the efficiency of MSCs transplantation in T2D patients.

SUBMITTER: Miroshnichenko S 

PROVIDER: S-EPMC7312015 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Apolipoprotein A-I Supports MSCs Survival under Stress Conditions.

Miroshnichenko Svetlana S   Usynin Ivan I   Dudarev Alexey A   Nimaev Vadim V   Solovieva Anastasiya A  

International journal of molecular sciences 20200605 11


Clinical trials have shown the safety of mesenchymal stem/stromal cells (MSCs) transplantation, but the effectiveness of these treatments is limited. Since, transplanted MSCs will undergo metabolic disturbances in the bloodstream, we investigated the influence of blood plasmas of type 2 diabetes (T2D) patients on MSCs viability and examined whether apolipoprotein A-I (apoA-I) could protect cells from stressful conditions of serum deprivation (SD), hypoxia, and elevated concentrations of reactive  ...[more]

Similar Datasets

| S-EPMC7201005 | biostudies-literature
| S-EPMC4011886 | biostudies-literature
| S-EPMC3910998 | biostudies-literature
| S-EPMC7343901 | biostudies-literature
| S-EPMC6815438 | biostudies-literature
| S-EPMC9414282 | biostudies-literature
| S-EPMC7200794 | biostudies-literature
| S-EPMC10879866 | biostudies-literature
| S-EPMC5029693 | biostudies-literature
| S-EPMC9945522 | biostudies-literature